Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Craniopharyngioma.

John A Jane1, Edward R Laws

  • 1School of Medicine, University of Virginia, Charlottesville, VA 22908, USA.

Pituitary
|November 3, 2006
PubMed
Summary
This summary is machine-generated.

Craniopharyngiomas, benign parasellar tumors, require a multidisciplinary approach. Treatment involves tailored surgery, hormonal replacement for endocrinopathy, and often adjuvant radiation therapy for residual tumors.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multi-Center, Multi-National Outcomes Following Endoscopic Endonasal Resection of Nonfunctional Pituitary Adenomas.

Journal of neurological surgery. Part B, Skull base·2026
Same author

A contemporary, multiinstitutional analysis of transcription factor lineage in pituitary adenomas: comparative study of neuroimaging, histopathology, and clinical outcomes.

Journal of neurosurgery·2025
Same author

Predictors of biochemical remission after transsphenoidal surgery in a large cohort of acromegaly patients.

Pituitary·2024
Same author

Academic Neurosurgery Gender and Authorship Trends in the United States.

Neurosurgery·2024
Same author

Somatic Activating ESR1 Mutation in an Aggressive Prolactinoma.

The Journal of clinical endocrinology and metabolism·2024
Same author

Risk of new tumor, carotid stenosis, and stroke after stereotactic radiosurgery for pituitary tumor: A multicenter study of 2254 patients with imaging follow-up.

Neuro-oncology·2024
Same journal

Clinician decision-making in non-functioning pituitary adenomas: an Australian and New Zealand interdisciplinary survey study.

Pituitary·2026
Same journal

Does persistent hyperprolactinemia contribute to bone loss independently of estrogen deficiency in postmenopausal women?

Pituitary·2026
Same journal

Gauze swabbing technique for safe dissection of pituitary tumors.

Pituitary·2026
Same journal

Postoperative changes in circulating brain injury biomarkers in relation to long-term fatigue and cognitive outcomes after surgery for nonfunctioning pituitary adenomas.

Pituitary·2026
Same journal

Pituitary metastasis as an endocrine-neuro-ophthalmologic emergency: clinical red flags and outcomes from a contemporary tertiary-center series.

Pituitary·2026
Same journal

GH responsiveness to corticotropin-releasing hormone identifies corticotroph-like somatotroph adenomas in acromegaly.

Pituitary·2026
See all related articles

Area of Science:

  • Neurosurgery
  • Endocrinology
  • Oncology

Background:

  • Craniopharyngiomas are benign tumors originating in the parasellar region.
  • These tumors present as cystic, solid, or mixed masses, affecting patients across a bimodal age distribution without gender bias.
  • Clinical manifestations include endocrinopathy and mass effect symptoms due to tumor growth.

Purpose of the Study:

  • To outline the diagnostic and therapeutic strategies for craniopharyngiomas.
  • To emphasize the necessity of a multidisciplinary approach in managing these complex tumors.
  • To detail the current standards of care, including surgical interventions and adjuvant therapies.

Main Methods:

  • Comprehensive review of diagnostic evaluation and treatment modalities for craniopharyngiomas.

Related Experiment Videos

  • Emphasis on personalized surgical approaches based on tumor characteristics and patient factors.
  • Integration of endocrinological management and adjuvant therapies like radiation and radiosurgery.

    • Main Results:

    • Endocrinopathy requires prompt recognition and hormonal replacement therapy.
    • Surgery is the primary treatment, with approaches varying from craniotomy/transsphenoidal surgery for solid tumors to intracavitary therapies for cystic lesions.
    • Adjuvant radiation or radiosurgery is often necessary for subtotally resected or residual tumors.

    Conclusions:

    • Craniopharyngioma management necessitates a multidisciplinary team approach.
    • Tailored surgical strategies and timely hormonal replacement are crucial for optimal outcomes.
    • Long-term follow-up is essential for all patients treated for craniopharyngiomas.